# EDGAR Filing Document

**Accession Number:** 0000820313
**File Stem:** 0001104659-26-007259
**Filing Date:** 2026-1
**Character Count:** 58535
**Document Hash:** 39f0b60bb7eb02f5aa19152e7409be97
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-007259.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001104659-26-007259

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260128

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMPHENOL CORP /DE/
- **CENTRAL INDEX KEY:** 0000820313
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC CONNECTORS [3678]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 222785165
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10879
- **FILM NUMBER:** 26569010

**BUSINESS ADDRESS:**
- **STREET 1:** 358 HALL AVE
- **CITY:** WALLINGFORD
- **STATE:** CT
- **ZIP:** 06492
- **BUSINESS PHONE:** 2032658900

?xml version='1.0' encoding='ASCII'? AMPHENOL CORPORATION_ January 28, 2026

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

### FORM 8-K
**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **January 28, 2026**

### AMPHENOL CORPORATION
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **1-10879** | **22-2785165** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| **358 Hall Avenue, Wallingford, Connecticut** | **06492** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(203) 265-8900**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock, $0.001 par value | APH | New York Stock Exchange |
| 3.125% Senior Notes due 2032 | APH32 | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On January 28, 2026, Amphenol Corporation (the "Company") issued a press release setting forth the Company's financial results for the quarter and year ended December 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This Current Report on Form 8-K may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and other related laws, which relate to future events and are subject to risks and uncertainties. The forward-looking statements, which address the Company's expected business and financial performance and financial condition, among other matters, may contain words and terms such as: "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "guidance," "intend," "look ahead," "may," "ongoing," "optimistic," "plan," "potential," "predict," "project," "seek," "should," "target," "will," or "would" and other words and terms of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity, effective tax rate, interest rates, the expected timing for the closing of certain acquisitions or other matters. A further description of these uncertainties and other risks can be found under the caption "Risk Factors" in Part I, Item 1A and elsewhere in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as well as other reports filed with the Securities and Exchange Commission, including, but not limited to, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These or other uncertainties could cause the Company's actual future results to be materially different from those expressed in any forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

The information set forth in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Document Description** |
| 99.1 | [Press Release dated January 28, 2026](aph-20260128xex99d1.htm) |
| <br>104 | <br>Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | By: | AMPHENOL CORPORATION<br>/s/ Craig A. Lampo |
|  |  | Craig A. Lampo |
|  |  | Executive Vice President and Chief Financial Officer |
| Date: January 28, 2026 |  |  |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| **Amphenol** | **News Release** |

---

***World Headquarters***

358 Hall Avenue

Wallingford, CT 06492

Telephone (203) 265-8900

**AMPHENOL REPORTS RECORD FOURTH QUARTER** 

**AND FULL YEAR 2025 RESULTS**

**Fourth Quarter 2025 Highlights:**

● Sales of $6.4 billion, up 49% in U.S. dollars and 37% organically compared to the fourth quarter of 2024

● GAAP Diluted EPS <sup></sup> of $0.93, up 58% compared to prior year

● Adjusted Diluted EPS <sup></sup> of $0.97, up 76% compared to prior year

● GAAP and Adjusted Operating Margin <sup></sup> of 26.8% and 27.5% , respectively

● Operating and Free Cash Flow of $1.7 billion and $1.5 billion , respectively

● Completed Trexon acquisition

**Full Year 2025 Highlights:**

● Sales of $23.1 billion, up 52% in U.S. dollars and 38% organically compared to the full year 2024

● GAAP Diluted EPS <sup></sup> of $3.34, up 74% compared to prior year

● Adjusted Diluted EPS <sup></sup> of $3.34, up 77% compared to prior year

● GAAP and Adjusted Operating Margin <sup></sup> of 25.4% and 26.2% , respectively

● Operating and Free Cash Flow of $5.4 billion and $4.4 billion , respectively

● Completed five acquisitions

● Signed agreement to acquire CommScope's CCS business, and closed on the acquisition in January 2026

● Returned nearly $1.5 billion to shareholders

Wallingford, Connecticut, January 28, 2026. Amphenol Corporation (NYSE: APH) today reported record fourth quarter and full year 2025 results.

"We are pleased to have closed 2025 with record fourth quarter and full-year sales and Adjusted Diluted EPS, both significantly exceeding the high end of our guidance," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "Sales in the fourth quarter and for the full year increased from prior year by 49% and 52%, respectively, driven by strong organic growth in virtually all of our end markets, including exceptional organic growth in the IT datacom market, as well as contributions from the Company's acquisition program. For both the quarter and full year we once again realized excellent profitability with Adjusted Operating Margin reaching 27.5% and 26.2%, respectively. We are extremely proud of the Company's outstanding performance during the quarter and for the full year 2025."

Throughout 2025, the Company continued to deploy its financial strength in a variety of ways to increase shareholder value. During the fourth quarter, the Company purchased 1.3 million shares of its common stock for $171 million and paid dividends of $202 million, resulting in total capital returned to shareholders of nearly $1.5 billion in 2025.

Amphenol remains focused on expanding its growth opportunities through a deep commitment to developing enabling technologies for customers across its served end markets, an ongoing strategy of market and geographic diversification as well as an active and successful acquisition program. To that end, the Company completed five acquisitions during 2025, including the previously announced closing of the Trexon acquisition in November. In addition, on January 12, 2026, the Company announced the closing of its acquisition of CommScope's Connectivity and Cable Solutions (CCS) business. As previously disclosed, Amphenol expects the CCS business to generate full-year 2026 sales of approximately $4.1 billion and add approximately $0.15 to Amphenol's 2026 Adjusted Diluted EPS.

**First Quarter 2026 Outlook**

Assuming the continuation of current market conditions as well as constant exchange rates, for the first quarter of 2026, Amphenol expects sales to be in the range of $6.90 billion to $7.00 billion, representing a 43% to 45% increase over the prior year quarter. Adjusted Diluted EPS is expected to be in the range of $0.91 to $0.93, representing a 44% to 48% increase from the first quarter of 2025. This guidance includes approximately $900 million in sales and $0.02 in Adjusted Diluted EPS accretion from the CCS business.

Mr. Norwitt continued, "I am very pleased with the Company's strong finish to a very successful 2025. The revolution in electronics continues to accelerate, with new innovations creating exciting growth opportunities for Amphenol across each of our diversified end markets. In turn, we have expanded our range of high-technology interconnect products, both through our organic innovation efforts as well as through our successful acquisition program. This expanded technology position coupled with our unique entrepreneurial culture has strengthened our competitive advantage. Our ongoing drive to leverage that competitive advantage and thereby create sustained financial strength has established an excellent base for the Company's future performance. I am confident in the ability of our outstanding entrepreneurial management team to continue to dynamically adjust to changing market conditions, to capitalize on the wide array of growth opportunities that arise in all market cycles and to continue to generate sustainable long-term value for our shareholders and other stakeholders."

------

**Conference Call and Webcast Details**

The Company will host a conference call to discuss its fourth quarter and full-year results at 1:00 PM (EST) on Wednesday, January 28, 2026. The toll-free dial-in number is 1-833-470-1428 and the International toll number is +1-646-844-6383; Access code: 133698.&nbsp;&nbsp;&nbsp;&nbsp;

A live webcast as well as a replay of the call can be accessed through the Investor Relations section of the Company's website at <u>https://investors.amphenol.com</u>.

**About Amphenol**

Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit <u>www.amphenol.com</u>.

**Non-GAAP Financial Measures**

The financial statements included within this press release are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP" or "U.S. GAAP"). This press release also contains certain non-GAAP financial measures, including Adjusted Operating Income, Adjusted Operating Margin, Adjusted Net Income attributable to Amphenol Corporation, Adjusted Effective Tax Rate, Adjusted Diluted EPS, Organic Net Sales Growth, and Free Cash Flow (collectively, "non-GAAP financial measures"), which are intended to supplement the reported GAAP results. Management utilizes these non-GAAP financial measures as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company's financial performance, communicating operating results to the Company's Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company's overall financial performance, trends and period-over-period comparative results. Non-GAAP financial measures related to operating income, operating margin, net income attributable to Amphenol Corporation, effective tax rate and diluted EPS exclude income and expenses that are not directly related to the Company's operating performance during the periods presented. Items excluded in the presentation of these non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, the excess tax benefits related to stock-based compensation and certain other discrete tax items including, but not limited to, (i) the impact of tax audits relating to prior periods and (ii) significant changes in tax law. Non-GAAP financial measures related to net sales exclude the impact related to foreign currency exchange and acquisitions. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures are included at the end of this press release. However, such non-GAAP financial measures are included for supplemental purposes only and should not be considered in isolation or as a substitute for or superior to the related U.S. GAAP financial measures. In addition, these non-GAAP financial measures are not necessarily the same or comparable to similar measures presented by other companies as such measures may be calculated differently or may exclude different items. The non-GAAP financial measures are defined within the "Supplemental Financial Information" table at the end of this press release and should be read in conjunction with the Company's financial statements presented in accordance with U.S. GAAP.

**Forward-Looking Statements**

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based on our management's assumptions and beliefs about future events or circumstances using information currently available, and as a result, they are subject to risks and uncertainties. Forward-looking statements address events or developments that Amphenol Corporation expects or believes may or will occur in the future. These forward-looking statements, which address the Company's expected business and financial performance and financial condition, among other matters, may contain words and terms such as: "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "guidance," "intend," "look ahead," "may," "ongoing," "optimistic," "plan," "potential," "predict," "project," "seek," "should," "target," "will" or "would" and other words and terms of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity, effective tax rate, interest rates, anticipated benefits of certain acquisitions, financing sources, the expected timing for the closing of certain acquisitions or other matters. Although the Company believes the expectations reflected in all forward-looking statements, including those we may make regarding first quarter 2026 sales and Adjusted Diluted EPS for the Company, as well as the full-year and first quarter 2026 sales and Adjusted Diluted EPS for CCS, are based upon reasonable assumptions, the expectations may not be attained or there may be material deviation. Readers and investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

There are risks and uncertainties that could cause actual results to differ materially from these forward-looking statements, which include, but are not limited to, the following: political, economic, military and other risks related to operating in countries outside the United States, as well as changes in general economic conditions, geopolitical conditions, U.S. and other country's trade policies, export control laws, sanctions, legislation, treaties and tariffs and other factors beyond the Company's control; uncertainties associated with an economic slowdown or recession in any of the Company's end markets that could negatively affect the financial condition of our customers and could result in reduced demand; risks and impacts associated with adverse public health developments, including epidemics and pandemics; risks associated with our inability to obtain certain raw materials and components, as well as the increasing cost of certain of the Company's raw materials and components; cybersecurity threats and techniques used to disrupt operations and gain unauthorized access to our information technology systems, including, but not limited to, malware, social engineering/phishing, credential harvesting, ransomware, malfeasance by insiders, human or technological error and other increasingly sophisticated attacks, that continue to expand and evolve, including through the use of artificial intelligence and machine learning, which could, among other things, impair our information technology systems and disrupt business operations, result in reputational damage that may cause the loss of existing or future customers, loss of our intellectual property, the loss of or inability to access confidential information and critical business, financial or other data, and/or cause the release of highly sensitive confidential or personal information, and potentially lead to litigation and/or governmental investigations, fines and other penalties, among other risks, and risks and impacts associated with an increasingly demanding regulatory environment surrounding information security and privacy, including additional fines, penalties and other related costs; negative impacts caused by extreme weather conditions and natural catastrophic events, including those caused or intensified by climate change and global warming; risks associated with the improper conduct by any of our employees, customers, suppliers, distributors

------

or any other business partners which could impair our business reputation and financial results and could result in our non-compliance with anti-corruption laws and regulations of the U.S. government and various foreign jurisdictions; changes in exchange rates of the various currencies in which the Company conducts business; the risks associated with the Company's dependence on attracting, recruiting, hiring and retaining skilled employees, including as part of our various management teams; risks and difficulties in trying to compete successfully on the basis of technology innovation, product quality and performance, price, customer service and delivery time; the Company's dependence on end market dynamics to sell its products, particularly certain end markets that are subject to cyclical and at times rapid periods of reduced demand; difficulties and unanticipated expenses in connection with purchasing and integrating newly acquired businesses, including the potential for the impairment of goodwill and other intangible assets; events beyond the Company's control that could lead to an inability to meet its financial and other covenants and requirements, which could result in a default under the Company's revolving credit facility or any of our various senior notes; risks associated with the Company's inability to access the global capital markets on favorable terms, including as a result of significant deterioration of general economic or capital market conditions, or as a result of a downgrade in the Company's credit rating; changes in interest rates; government contracting risks that the Company may be subject to, including laws and regulations governing reporting obligations, performance of government contracts and related risks associated with conducting business with the U.S. and other foreign governments or their suppliers (both directly and indirectly); governmental export and import controls as well as sanctions and trade embargoes that certain of our products may be subject to, including export licensing, customs regulations, economic sanctions and other laws; changes in fiscal and tax policies, audits and examinations by taxing authorities, laws, regulations and guidance in the United States and foreign jurisdictions; any difficulties in enforcing and protecting the Company's intellectual property rights; litigation, customer claims, voluntary or forced product recalls, governmental investigations, criminal liability or environmental matters including changes to laws and regulations to which the Company may be subject; incremental costs, risks and regulations associated with efforts to combat the negative effects of climate change; and risks associated with the increasing scrutiny and expectations regarding environmental, social and corporate governance matters that could result in additional costs or risks or otherwise adversely impact our business.

A further description of these uncertainties and other risks can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Reports on Form 10-Q and the Company's other reports filed with the Securities and Exchange Commission. These or other uncertainties not identified in these documents (that we either currently do not expect to have an adverse effect on our business or that we are unable to predict or identify at this time) may cause the Company's actual future results to be materially different from those expressed in any forward-looking statements. Our forward-looking statements may also be impacted by, among other things, future tax, regulatory and other legal changes that may arise in any of the jurisdictions in which we operate. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

------

**Contact:**

Sherri Scribner

Vice President, Strategy and Investor Relations

203-265-8820

<u>IR@amphenol.com</u>

------

**AMPHENOL CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

**(Unaudited)**

**(dollars and shares in millions, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Twelve Months Ended**  | **Twelve Months Ended**  |
|  | **December 31,**  | **December 31,**  | **December 31,**  | **December 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Net sales | $6439.0 | $4317.9 | $23094.7 | $15222.7 |
| Cost of sales **(1)** | 3977.9 | 2837.2 | 14577.0 | 10083.0 |
| Gross profit  | 2461.1 | 1480.7 | 8517.7 | 5139.7 |
| &nbsp;&nbsp;Acquisition-related expenses | 47.4 | 12.0 | 103.4 | 127.4 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 691.0 | 515.0 | 2545.7 | 1855.4 |
| Operating income | 1722.7 | 953.7 | 5868.6 | 3156.9 |
| Interest expense | (129.7) | (66.9) | (367.8) | (217.0) |
| Other income (expense), net | 55.8 | 23.6 | 99.9 | 72.0 |
| Income before income taxes | 1648.8 | 910.4 | 5600.7 | 3011.9 |
| Provision for income taxes **(2)** | (443.6) | (158.4) | (1295.4) | (570.3) |
| Net income | 1205.2 | 752.0 | 4305.3 | 2441.6 |
| &nbsp;&nbsp;Less: Net income attributable to noncontrolling interests | (9.7) | (5.8) | (35.0) | (17.6) |
| Net income attributable to Amphenol Corporation | $1195.5 | $746.2 | $4270.3 | $2424.0 |
| Net income attributable to Amphenol Corporation per common share — Basic | $0.98 | $0.62 | $3.51 | $2.01 |
| Weighted average common shares outstanding — Basic  | 1225.6 | 1207.8 | 1218.2 | 1203.8 |
| Net income attributable to Amphenol Corporation per common share — Diluted **(3)** | $0.93 | $0.59 | $3.34 | $1.92 |
| Weighted average common shares outstanding — Diluted | 1288.7 | 1268.1 | 1277.5 | 1263.6 |
| Dividends declared per common share | $0.25 | $0.165 | $0.745 | $0.55 |

---

------

**Note 1** For the twelve months ended December 31, 2025, Cost of sales includes the amortization of acquisition-related inventory step-up costs of $77.8 million ($59.6 million after-tax, or $0.05 per share) associated with the acquisition of the Outdoor Wireless Networks segment and Distributed Antenna Systems business (collectively, the "Andrew Business") from CommScope that closed during the first quarter of 2025. For the twelve months ended December 31, 2024, Cost of sales includes the amortization of acquisition-related inventory step-up costs of $18.2 million ($14.0 million after-tax, or $0.01 per share) associated with the Carlisle Interconnect Technologies ("CIT") acquisition that closed during the second quarter of 2024.

**Note 2** Provision for income taxes for the three months ended December 31, 2025 and 2024 includes excess tax benefits related to stock-based compensation of $84.0 million ($0.07 per share) and $60.6 million ($0.05 per share), respectively. Provision for income taxes for the three months ended December 31, 2025 also includes a discrete tax item of $100.0 million ($0.08 per share) related to an accrual recorded for notices received by certain subsidiaries in China from relevant tax authorities challenging tax positions taken over up to an eight year period.

Provision for income taxes for the twelve months ended December 31, 2025 includes excess tax benefits related to stock-based compensation of $246.6 million ($0.19 per share) and the discrete tax item of $100.0 million ($0.08 per share) discussed above. Provision for income taxes for the twelve months ended December 31, 2024 includes excess tax benefits related to stock-based compensation of $142.6 million ($0.11 per share) and a discrete tax benefit of $18.6 million ($0.01 per share) related to the settlement of tax audits and associated lapses of statutes of limitation, along with a difference in a non-U.S. tax filing position.

**Note 3** Net income per share for the three months ended December 31, 2025 and 2024 includes the excess tax benefits related to stock-based compensation discussed in Note 2. Net income per share for the three months ended December 31, 2025 also includes the discrete tax item discussed in Note 2. Net income per share for the three months ended December 31, 2025 also includes acquisition-related expenses of $47.4 million ($42.6 million after-tax, or $0.03 per share), comprised primarily of external transaction costs associated with acquisitions and the amortization related to the value associated with acquired backlog resulting from acquisitions. Net income per share for the three months ended December 31, 2024 also includes acquisition-related expenses of $12.0 million ($9.6 million after-tax, or $0.01 per share), comprised primarily of external transaction costs associated with acquisitions.

Net income per share for the twelve months ended December 31, 2025 and 2024 includes the excess tax benefits related to stock-based compensation discussed in Note 2. Net income per share for the twelve months ended December 31, 2025 and 2024 also includes the discrete tax item and benefit discussed in Note 2. Net income per share for the twelve months ended December 31, 2025 also includes acquisition-related expenses of $181.2 million ($148.8 million after-tax, or $0.12 per share), comprised primarily of (i) the amortization of acquisition-related inventory step-up costs discussed in Note 1 and (ii) external transaction costs related to acquisitions and the amortization related to the value associated with acquired backlog resulting from acquisitions (such acquisition-related expenses aggregating $103.4 million are presented separately in the Condensed Consolidated Statements of Income). Net income per share for the twelve months ended December 31, 2024 also includes acquisition-related expenses of $145.6 million ($119.3 million after-tax, or $0.09 per share), comprised primarily of (i) the amortization related to the value associated with acquired backlog resulting from the CIT acquisition and external transaction costs associated with acquisitions (such acquisition-related expenses aggregating $127.4 million are presented separately in the Condensed Consolidated Statements of Income), and (ii) the amortization of acquisition-related inventory step-up costs discussed in Note 1.

Excluding these effects and the impact of rounding, Adjusted Diluted EPS, a non-GAAP financial measure which is defined and reconciled to its most comparable GAAP financial measure in this press release, was $0.97 and $0.55 for the three months ended December 31, 2025 and 2024, respectively, and $3.34 and $1.89 for the twelve months ended December 31, 2025 and 2024, respectively.

------

**AMPHENOL CORPORATION**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

**(dollars in millions)**

---

| | | |
|:---|:---|:---|
|  | **December 31,** <br>**2025** | **December 31,**<br>**2024** |
| **ASSETS** |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $11130.6 | $3317.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | 303.6 | 18.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and short-term investments | 11434.2 | 3335.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, less allowance for doubtful accounts of $99.3 and $66.5, respectively | 4717.1 | 3287.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 3424.9 | 2545.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 691.0 | 517.0 |
| Total current assets | 20267.2 | 9686.0 |
| Property, plant and equipment, less accumulated depreciation of $3,096.0 and $2,464.3, respectively | 2305.6 | 1711.8 |
| Goodwill | 10575.4 | 8236.2 |
| Other intangible assets, net | 2241.4 | 1225.1 |
| Other long-term assets | 847.3 | 581.1 |
| Total Assets | $36236.9 | $21440.2 |
| **LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $2661.9 | $1819.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries, wages and employee benefits | 767.7 | 529.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | 482.9 | 199.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued dividends | 306.7 | 199.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued expenses | 1646.4 | 934.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | 937.2 | 401.7 |
| Total current liabilities | 6802.8 | 4083.8 |
| Long-term debt, less current portion | 14564.8 | 6484.4 |
| Accrued pension and postretirement benefit obligations | 138.2 | 129.8 |
| Deferred income taxes | 432.9 | 376.7 |
| Other long-term liabilities | 788.5 | 509.4 |
| Total Liabilities | 22727.2 | 11584.1 |
| Redeemable noncontrolling interests | 9.3 | 8.7 |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 1.2 | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 4232.9 | 3601.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 9854.3 | 7105.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost | (195.8) | (199.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (479.5) | (716.3) |
| Total stockholders' equity attributable to Amphenol Corporation | 13413.1 | 9792.0 |
| Noncontrolling interests | 87.3 | 55.4 |
| Total Equity | 13500.4 | 9847.4 |
| Total Liabilities, Redeemable Noncontrolling Interests and Equity | $36236.9 | $21440.2 |

---

------

**AMPHENOL CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW**

**(Unaudited)**

**(dollars in millions)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Twelve Months Ended**  | **Twelve Months Ended**  |
|  | **December 31,**  | **December 31,**  | **December 31,**  | **December 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| <u>Cash from operating activities:</u> |  |  |  |  |
| Net income | $1205.2 | $752.0 | $4305.3 | $2441.6 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 249.0 | 143.8 | 922.4 | 572.5 |
| &nbsp;&nbsp;Stock-based compensation expense | 40.6 | 29.6 | 135.4 | 109.5 |
| &nbsp;&nbsp;Deferred income tax benefit | (25.1) | (49.2) | (65.6) | (82.8) |
| &nbsp;&nbsp;Net change in components of working capital | 402.9 | (12.9) | (32.3) | (210.5) |
| &nbsp;&nbsp;Net change in other long-term assets and liabilities | (150.4) | (16.2) | 109.5 | (15.6) |
| Net cash provided by operating activities | 1722.2 | 847.1 | 5374.7 | 2814.7 |
| <u>Cash from investing activities:</u> |  |  |  |  |
| &nbsp;&nbsp;Capital expenditures | (253.7) | (199.8) | (996.6) | (665.4) |
| &nbsp;&nbsp;Proceeds from disposals of property, plant and equipment | 7.2 | 0.7 | 14.8 | 7.8 |
| &nbsp;&nbsp;Purchases of investments | (221.9) | (5.5) | (309.3) | (26.2) |
| &nbsp;&nbsp;Sales and maturities of investments | 11.3 | 8.0 | 27.6 | 189.7 |
| &nbsp;&nbsp;Acquisitions, net of cash acquired | (1046.4) | (56.6) | (3818.6) | (2156.4) |
| &nbsp;&nbsp;Other, net |  | 2.8 |  | 1.9 |
| Net cash used in investing activities | (1503.5) | (250.4) | (5082.1) | (2648.6) |
| <u>Cash from financing activities:</u> |  |  |  |  |
| &nbsp;&nbsp;Proceeds from issuance of senior notes and other long-term debt | 7491.7 | 1491.2 | 8921.7 | 2991.3 |
| &nbsp;&nbsp;Repayments of senior notes and other long-term debt | (0.4) | (10.7) | (401.7) | (364.4) |
| &nbsp;&nbsp;Borrowings (repayments) under commercial paper programs, net |  |  |  |  |
| &nbsp;&nbsp;Payment of costs related to debt financing | (60.0) | (13.7) | (89.1) | (28.4) |
| &nbsp;&nbsp;Purchase of treasury stock | (171.3) | (168.9) | (665.2) | (689.3) |
| &nbsp;&nbsp;Proceeds from exercise of stock options | 107.6 | 127.1 | 553.0 | 447.4 |
| &nbsp;&nbsp;Distributions to and purchases of noncontrolling interests | (0.3) | (12.2) | (5.8) | (33.0) |
| &nbsp;&nbsp;Dividend payments | (201.9) | (198.9) | (802.2) | (595.1) |
| &nbsp;&nbsp;Treasury lock settlement | (88.0) |  | (88.0) |  |
| &nbsp;&nbsp;Other, net | (0.2) | 0.2 | 0.5 | 1.4 |
| Net cash provided by financing activities | 7077.2 | 1214.1 | 7423.2 | 1729.9 |
| Effect of exchange rate changes on cash and cash equivalents | 35.4 | (56.8) | 97.8 | (54.0) |
| Net increase in cash and cash equivalents | 7331.3 | 1754.0 | 7813.6 | 1842.0 |
| Cash and cash equivalents balance, beginning of period | 3799.3 | 1563.0 | 3317.0 | 1475.0 |
| Cash and cash equivalents balance, end of period | $11130.6 | $3317.0 | $11130.6 | $3317.0 |
| Cash paid for: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | $99.3 | $66.9 | $288.1 | $179.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net | 256.7 | 133.9 | 1084.1 | 650.0 |

---

------

**AMPHENOL CORPORATION**

**SEGMENT INFORMATION**

**(Unaudited)**

**(dollars in millions)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Twelve Months Ended**  | **Twelve Months Ended**  |
|  | **December 31,**  | **December 31,**  | **December 31,**  | **December 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| <u>Net sales:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Communications Solutions | $3423.0 | $1928.0 | $12056.0 | $6323.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Harsh Environment Solutions | 1652.5 | 1261.9 | 5881.7 | 4417.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interconnect and Sensor Systems | 1363.5 | 1128.0 | 5157.0 | 4481.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Net sales | $6439.0 | $4317.9 | $23094.7 | $15222.7 |
| <u>Operating income:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Communications Solutions | $1113.8 | $501.9 | $3746.6 | $1569.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Harsh Environment Solutions | 455.6 | 305.4 | 1541.4 | 1093.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interconnect and Sensor Systems | 273.9 | 209.6 | 1005.1 | 825.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | (40.6) | (29.6) | (135.4) | (109.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquisition-related inventory step-up costs |  |  | (77.8) | (18.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related expenses | (47.4) | (12.0) | (103.4) | (127.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | (32.6) | (21.6) | (107.9) | (76.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Operating income | $1722.7 | $953.7 | $5868.6 | $3156.9 |
| <u>Operating margin (%):</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Communications Solutions | 32.5% | 26.0% | 31.1% | 24.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Harsh Environment Solutions | 27.6% | 24.2% | 26.2% | 24.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interconnect and Sensor Systems | 20.1% | 18.6% | 19.5% | 18.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | -0.6% | -0.7% | -0.6% | -0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquisition-related inventory step-up costs | 0.0% | 0.0% | -0.3% | -0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related expenses | -0.7% | -0.3% | -0.4% | -0.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | -0.5% | -0.5% | -0.5% | -0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Operating margin (%) | 26.8% | 22.1% | 25.4% | 20.7% |

---

------

**AMPHENOL CORPORATION**

**SUPPLEMENTAL FINANCIAL INFORMATION**

**RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**(Unaudited)**

**(dollars in millions, except per share data)**

Management utilizes the non-GAAP financial measures defined below as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company's financial performance, communicating operating results to the Company's Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company's overall financial performance, trends and period-over-period comparative results. Non-GAAP financial measures related to net sales exclude the impact of foreign currency exchange rates and acquisitions. Non-GAAP financial measures related to operating income, operating margin, net income attributable to Amphenol Corporation, effective tax rate and diluted EPS exclude income and expenses that are not directly related to the Company's operating performance during the periods presented. Items excluded from such non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, the excess tax benefits related to stock-based compensation and certain other discrete tax items including, but not limited to, (i) the impact of tax audits relating to prior periods and (ii) significant changes in tax law. The following non-GAAP financial information is included for supplemental purposes only and should not be considered in isolation or as a substitute for or superior to the related U.S. GAAP financial measures. In addition, these non-GAAP financial measures are not necessarily the same or comparable to similar measures presented by other companies as such measures may be calculated differently or may exclude different items. Such non-GAAP financial measures should be read in conjunction with the Company's financial statements presented in accordance with U.S. GAAP.

The following are reconciliations of non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures for the periods presented:

**NET SALES**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | **Percentage Growth (relative to same prior year period) (1)** | **Percentage Growth (relative to same prior year period) (1)** | **Percentage Growth (relative to same prior year period) (1)** | **Percentage Growth (relative to same prior year period) (1)** | **Percentage Growth (relative to same prior year period) (1)** |
|  |  |  | **Net sales** | **Foreign** | **Constant** |  | **Organic** |
|  |  |  | **growth in** | **currency** | **Currency Net** | **Acquisition** | **Net Sales** |
|  |  |  | **U.S. Dollars (2)** | **impact (3)** | **Sales Growth (5)** | **impact (4)** | **Growth (5)** |
| **Three Months Ended December 31,**  | **2025** | **2024** | **(GAAP)** | **(non-GAAP)** | **(non-GAAP)** | **(non-GAAP)** | **(non-GAAP)** |
| &nbsp;&nbsp;**Net sales by segment:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Communications Solutions | $3423.0 | $1928.0 | 78% | —% | 77% | 17% | 60% |
| &nbsp;&nbsp;&nbsp;&nbsp;Harsh Environment Solutions | 1652.5 | 1261.9 | 31% | 1% | 30% | 8% | 21% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interconnect and Sensor Systems | 1363.5 | 1128.0 | 21% | 2% | 18% | 3% | 16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $6439.0 | $4317.9 | 49% | 1% | 48% | 11% | 37% |
| **Twelve Months Ended December 31,**  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;**Net sales by segment:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Communications Solutions | $12056.0 | $6323.8 | 91% | —% | 91% | 20% | 71% |
| &nbsp;&nbsp;&nbsp;&nbsp;Harsh Environment Solutions | 5881.7 | 4417.4 | 33% | 1% | 32% | 15% | 17% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interconnect and Sensor Systems | 5157.0 | 4481.5 | 15% | 1% | 14% | 1% | 13% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $23094.7 | $15222.7 | 52% | 1% | 51% | 13% | 38% |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;**(1)** Percentages in this table were calculated using actual, unrounded results; therefore, the sum of the components may not add due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;**(2)** **Net sales growth in U.S. dollars** is calculated based on Net sales as reported in the Condensed Consolidated Statements of Income. While the term "net sales growth in U.S. dollars" is not considered a U.S. GAAP financial measure, for purposes of this table, we derive the reported (GAAP) measure based on GAAP results, which serves as the basis for the reconciliation to its comparable non-GAAP financial measures.

&nbsp;&nbsp;&nbsp;&nbsp;**(3)** **Foreign currency translation impact**, a non-GAAP measure, represents the percentage impact on net sales resulting from foreign currency exchange rate changes in the current reporting period(s) compared to the same respective period(s) in the prior year. Such amount is calculated by subtracting net sales for the current reporting period(s) translated at average foreign currency exchange rates for the respective prior year period(s) from net sales for the current reporting period(s), taken as a percentage of the respective prior year period(s) net sales.

&nbsp;&nbsp;&nbsp;&nbsp;**(4)** **Acquisition impact**, a non-GAAP measure, represents the percentage impact on net sales resulting from acquisitions that have not been included in the Company's consolidated results for the full current period(s) and/or prior comparable period(s) presented. Such net sales related to these acquisitions do not reflect the underlying growth of the Company on a comparative basis. Acquisition impact is calculated as a percentage of the respective prior year period(s) net sales.

&nbsp;&nbsp;&nbsp;&nbsp;**(5)** The following are definitions of certain non-GAAP financial measures presented in the table(s) above, which may be referred to within this press release. For purposes of this press release, the terms "constant currencies" and "organically" have the same meaning as the following non-GAAP financial measures, respectively:

**Constant Currency Net Sales Growth** is defined as the period-over-period percentage change in net sales growth, excluding the impact of changes in foreign currency exchange rates. The Company's results are subject to volatility related to foreign currency translation fluctuations. As such, management evaluates the Company's sales performance based on actual sales growth in U.S. dollars, as well as Organic Net Sales Growth (defined below) and Constant Currency Net Sales Growth, and believes that such information is useful to investors to assess the underlying sales trends.

**Organic Net Sales Growth** is defined as the period-over-period percentage change in net sales growth resulting from operating volume, pricing changes and sales mix and excludes (i) the foreign currency translation impact, which is outside the control of the Company, and (ii) the acquisition impact, both as described above and which do not reflect the underlying growth of the Company on a comparative basis. Management evaluates the Company's sales performance based on actual sales growth in U.S. dollars, as well as Constant Currency Net Sales Growth (defined above) and Organic Net Sales Growth, and believes that such information is useful to investors to assess the underlying sales trends.

------

**AMPHENOL CORPORATION**

**SUPPLEMENTAL FINANCIAL INFORMATION**

**RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES (continued)**

**(Unaudited)**

**(dollars in millions, except per share data)**

**OPERATING RESULTS**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  | **Three Months Ended December 31,**  |
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **2024** | **2024** |
|  | <br>**Operating**<br>**Income** | <br>**Operating**<br>**Margin (i)** | **Net Income**<br>**attributable to**<br>**Amphenol**<br>**Corporation** | <br>**Effective**<br>**Tax**<br>**Rate (i)** | <br><br>**Diluted**<br>**EPS** | <br>**Operating**<br>**Income** | <br>**Operating**<br>**Margin (i)** | **Net Income**<br>**attributable to**<br>**Amphenol**<br>**Corporation** | <br>**Effective**<br>**Tax**<br>**Rate (i)** | <br><br>**Diluted**<br>**EPS** |
| Reported (GAAP) | $1722.7 | 26.8% | $1195.5 | 26.9% | $0.93 | $953.7 | 22.1% | $746.2 | 17.4% | $0.59 |
| &nbsp;&nbsp;&nbsp;Acquisition-related expenses | 47.4 | 0.7 | 42.6 | (0.4) | 0.03 | 12.0 | 0.3 | 9.6 | (0.1) | 0.01 |
| &nbsp;&nbsp;&nbsp;Excess tax benefits related to stock-based compensation |  |  | (84.0) | 5.1 | (0.07) |  |  | (60.6) | 6.7 | (0.05) |
| &nbsp;&nbsp;&nbsp;Discrete tax items (iii) |  |  | 100.0 | (6.1) | 0.08 |  |  |  |  |  |
| Adjusted (non-GAAP) (iv) (v) | $1770.1 | 27.5% | $1254.1 | 25.5% | $0.97 | $965.7 | 22.4% | $695.2 | 24.0% | $0.55 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  | **Twelve Months Ended December 31,**  |
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **2024** | **2024** |
|  | <br>**Operating**<br>**Income** | <br>**Operating**<br>**Margin (i)** | **Net Income**<br>**attributable to**<br>**Amphenol**<br>**Corporation** | <br>**Effective**<br>**Tax**<br>**Rate (i)** | <br><br>**Diluted**<br>**EPS** | <br>**Operating**<br>**Income** | <br>**Operating**<br>**Margin (i)** | **Net Income**<br>**attributable to**<br>**Amphenol**<br>**Corporation** | <br>**Effective**<br>**Tax**<br>**Rate (i)** | <br><br>**Diluted**<br>**EPS** |
| Reported (GAAP) | $5868.6 | 25.4% | $4270.3 | 23.1% | $3.34 | $3156.9 | 20.7% | $2424.0 | 18.9% | $1.92 |
| &nbsp;&nbsp;&nbsp;Amortization of acquisition-related inventory step-up costs (ii) | 77.8 | 0.3 | 59.6 |  | 0.05 | 18.2 | 0.1 | 14.0 |  | 0.01 |
| &nbsp;&nbsp;&nbsp;Acquisition-related expenses | 103.4 | 0.4 | 89.2 | (0.2) | 0.07 | 127.4 | 0.8 | 105.3 | (0.3) | 0.08 |
| &nbsp;&nbsp;&nbsp;Excess tax benefits related to stock-based compensation |  |  | (246.6) | 4.4 | (0.19) |  |  | (142.6) | 4.7 | (0.11) |
| &nbsp;&nbsp;&nbsp;Discrete tax items (iii) |  |  | 100.0 | (1.8) | 0.08 |  |  | (18.6) | 0.6 | (0.01) |
| Adjusted (non-GAAP) (iv) (v) | $6049.8 | 26.2% | $4272.5 | 25.5% | $3.34 | $3302.5 | 21.7% | $2382.1 | 24.0% | $1.89 |

---

**FREE CASH FLOW**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Twelve Months Ended**  | **Twelve Months Ended**  |
|  | **December 31,**  | **December 31,**  | **December 31,**  | **December 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Operating Cash Flow (GAAP) | $1722.2 | $847.1 | $5374.7 | $2814.7 |
| Capital expenditures (GAAP) | (253.7) | (199.8) | (996.6) | (665.4) |
| Proceeds from disposals of property, plant and equipment (GAAP) | 7.2 | 0.7 | 14.8 | 7.8 |
| Free Cash Flow (non-GAAP) (v) | $1475.7 | $648.0 | $4392.9 | $2157.1 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;(i) While the terms "operating margin" and "effective tax rate" are not considered U.S. GAAP financial measures, for purposes of this table, we derive the reported (GAAP) measures based on GAAP results, which serve as the basis for the reconciliation to their comparable non-GAAP financial measures.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) Amortization of acquisition-related inventory step-up costs is reported within Cost of sales in the Condensed Consolidated Statements of Income.

&nbsp;&nbsp;&nbsp;&nbsp;(iii) In 2025, certain of the Company's subsidiaries based in China received notices from relevant tax authorities challenging tax positions taken over up to an eight year period. Although the Company believes its tax positions are appropriate and is currently discussing the matter with the relevant tax authorities, the Company has recorded an accrual of $100.0 million in the fourth quarter of 2025. The $100.0 million accrual represents the Company's current best estimate of the costs that may be incurred to resolve this matter, however the range of potential costs is estimated to be $100.0 million to approximately $300.0 million. The Company is unable to estimate the timing for resolution of this matter. In 2024, a discrete tax benefit of $18.6 million ($0.01 per share) related to the settlement of tax audits and associated lapses of statutes of limitation, along with a difference in a non-U.S. tax filing position.

&nbsp;&nbsp;&nbsp;&nbsp;(iv) All percentages and per share amounts in this table were calculated using actual, unrounded results; therefore, the sum of the components may not add due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;(v) The following are definitions of non-GAAP financial measures presented in the tables above, which may be referred to within this press release:

**Adjusted Operating Income** is defined as Operating income (as reported in the Condensed Consolidated Statements of Income), excluding income and expenses that are not directly related to the Company's operating performance during the periods presented.

**Adjusted Operating Margin** is defined as Adjusted Operating Income (as defined above) expressed as a percentage of Net sales (as reported in the Condensed Consolidated Statements of Income).

**Adjusted Net Income attributable to Amphenol Corporation** is defined as Net income attributable to Amphenol Corporation (as reported in the Condensed Consolidated Statements of Income), excluding income and expenses and their specific tax effects that are not directly related to the Company's operating performance during the periods presented.

**Adjusted Effective Tax Rate** is defined as Provision for income taxes (as reported in the Condensed Consolidated Statements of Income) expressed as a percentage of Income before income taxes (as reported in the Condensed Consolidated Statements of Income), each excluding income and expenses and their specific tax effects that are not directly related to the Company's operating performance during the periods presented.

**Adjusted Diluted EPS** is defined as diluted earnings per share (as reported in accordance with U.S. GAAP), excluding income and expenses and their specific tax effects that are not directly related to the Company's operating performance during the periods presented. Adjusted Diluted EPS is calculated as Adjusted Net Income attributable to Amphenol Corporation, as defined above, divided by the weighted average outstanding diluted shares (as reported in the Condensed Consolidated Statements of Income).

**Free Cash Flow** is defined as (i) Net cash provided by operating activities ("Operating Cash Flow" - as reported in accordance with U.S. GAAP) less (ii) capital expenditures (as reported in accordance with U.S. GAAP), net of proceeds from disposals of property, plant and equipment (as reported in accordance with U.S. GAAP), all of which are derived from the Condensed Consolidated Statements of Cash Flow. Free Cash Flow is an important liquidity measure for the Company, as we believe it is useful for management and investors to assess our ability to generate cash, as well as to assess how much cash can be used to reinvest in the growth of the Company or to return to stockholders through either stock repurchases or dividends.

------

**AMPHENOL CORPORATION**

**SUPPLEMENTAL FINANCIAL INFORMATION**

**RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES - GUIDANCE**

**(Unaudited)**

**(dollars in millions, except per share data)**

Management utilizes the non-GAAP financial measures defined earlier as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company's financial performance, communicating operating results to the Company's Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company's overall financial performance, trends and period-over-period comparative results. Adjusted Diluted EPS, a non-GAAP financial measure, excludes income and expenses that are not directly related to the Company's operating performance during the periods presented. Items excluded from such non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, the excess tax benefits related to stock-based compensation, and certain other discrete tax items including, but not limited to, (i) the impact of tax audits relating to prior periods and (ii) significant changes in tax law. Adjusted Diluted EPS is not necessarily the same or comparable to similar measures presented by other companies as such measures may be calculated differently or may exclude different items. Such non-GAAP financial measures should be read in conjunction with the Company's financial statements presented in accordance with U.S. GAAP.

The following is a reconciliation of current guidance for GAAP Diluted earnings per share (Diluted EPS) to Adjusted Diluted EPS (non-GAAP) for the first quarter of 2026:

---

| | |
|:---|:---|
|  | **GUIDANCE (1)** |
|  | **FIRST QUARTER 2026** |
| Diluted EPS (GAAP) | $0.81 - $0.83 |
| &nbsp;&nbsp;Acquisition-related costs, net of tax | $0.10  |
| Adjusted Diluted EPS (non-GAAP) (2) | $0.91 - $0.93 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;(1) Forward-looking Adjusted Diluted EPS reflected in our guidance excludes certain income and expenses, described above, that are not directly related to the Company's operating performance. Such items are excluded from our guidance for the forward-looking periods only to the extent that such items have either (i) already been reflected in periods reported and are therefore included in the forward-looking full-year period or (ii) the Company reasonably expects to record such items in the forward-looking periods presented and such amounts are estimable. The Company estimates acquisition-related costs, net of tax in the first quarter of 2026 of approximately $135.0 ($0.10 per share), which primarily relates to the acquisition of the CCS Business.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Per share amounts in this table were calculated using actual, unrounded results; therefore, the sum of the components may not add due to rounding.

------